As part of increasing the production rate and at the same time improving communication, Scandinavian ChemoTech AB (publ) is implementing changes in management. Jonathan Furelid, started as a consultant with the company in June and will have the role of Head of Investor Relations and join the management as of September 1, 2022. Anders Johnsson, was assigned the role of Head of Production during the summer and will now focus fully on managing and streamlining all production.

The commercial responsibilities for Vetiqure, that Anders held, will in the future be managed by CEO Mohan Frick.